NCT06458855Active, not recruiting
Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy
Pilot Trial: Pilot Study of Somatic-Autonomic Nerve Grafting Technique to Restore Erectile Function in Patients With Persistent Erectile Dysfunction Post Radical Prostatectomy
Source: ClinicalTrials.gov · Last updated 18 Apr 2025
Brief summary (registry, in English)
A single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing a somatic to autonomic nerve grafting procedure for restoration of erectile function in patients who have lost erectile function following radical prostatectomy for prostate cancer. During this study a total of 10 patients who have persistent erectile dysfunction for more than 18 months post prostatectomy will undergo a post radical prostatectomy nerve restoration procedure (PRP-NR).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 21 May 2024
- Start date
- 17 Jul 2024
- Primary completion date
- Mar 2027
- Lead sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
- Diseases
- Prostate cancer
- NCT number
- NCT06458855
What you commit to
- Study type: Interventional
- Planned participants: 10
- From 17 Jul 2024 to the primary completion date, Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with previous pelvic radiotherapy
Other illness
- Patients with pre-existing neurologic disease
- Patients with a history of bilateral surgeries for inguinal hernia repair.
Age
- Patients aged \< 18 years at diagnosis
Other
- Legally incapable patients
- Patients who are unable to complete questionnaires and have no companion to help complete them
Who the study is looking for
- Patients with persistent post prostatectomy erectile dysfunction more than 18 months from prostatectomy and which results in the inability to achieve intercourse with the aid of PDE5-I medications.
- Patients must have had good pre-prostatectomy erectile function with a baseline IIEF score of ≥17 on self-reported assessment of historic function.
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jewish General Hospital Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.